Cobram Estate Olives (CBO) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
8 Jul, 2026Executive summary
Sales increased by 13.5% year-over-year to AUD 123.5 million for the six months to 31 December 2024, driven by strong demand and effective marketing in both Australia and the U.S.A.
EBITDA rose 75% to AUD 14.5 million, while the after-tax loss improved to AUD 4.5 million from AUD 7.2 million last year.
Packaged goods sales were the main growth driver, with Australia up 20.9% and the U.S.A. up 18.5%; Cobram EstateĀ® branded sales soared 103.4% in the USA and 25.7% in Australia.
Operating cash flow before interest and tax grew 36% to AUD 43.6 million.
FY2025 is an 'on' year for Australian groves, with the crop expected to be materially larger than FY2024.
Financial highlights
Group olive oil sales revenue: $123.5m, up 13.5% year-over-year; net loss after tax: $4.5m, improved from $7.2m loss in 1HFY24.
EBITDA: $14.5m, up 75.4% year-over-year.
Cash flow from operations: $43.6m, up 36.2% year-over-year.
CapEx for the half was AUD 52.1 million, mainly for U.S. land acquisitions.
Net assets at AUD 316 million; adjusted asset value at AUD 890 million.
Outlook and guidance
Expect continued strength in sales, profitability, and operating cash flow in the second half, driven by robust demand in Australia and the USA.
CapEx will continue but at a lower level, with future focus on U.S. supply expansion; Australian capex to shift to maintenance after Boort mill expansion.
Anticipate materially higher EBITDA and profitability due to an on-year in Australia and a larger crop.
Material fair value gain from the Australian olive crop expected to be recognized in the FY2025 full year results.
Latest events from Cobram Estate Olives
- Sales and profit surged, with strong growth in Australia and the USA and a positive FY2025 outlook.CBO
H2 20249 Jul 2026 - Record sales, profit, and growth initiatives drive a positive outlook.CBO
AGM 20248 Jul 2026 - Record profit, strong sales growth, and U.S. expansion mark a transformative year.CBO
H2 202516 Jun 2026 - EBITDA ahead of guidance, net loss widened, capital raised for U.S. expansion and acquisition.CBO
H1 202612 Jun 2026 - Record profit, U.S. expansion, and sustainability drive long-term growth and shareholder value.CBO
AGM 202513 Nov 2025 - Major capital raise to fund rapid USA expansion, targeting 3,600 hectares and 9M+ litres of oil.CBO
Investor Presentation9 Sep 2025